What EUC Annex 22 Means for AI Validation and Testing
Annex 22 redefines AI validation in pharma, emphasizing data integrity, risk-based testing, explainability, and continuous monitoring to ensure AI models are reliable, transparent, and compliant in regulated manufacturing systems.